Patent · US Active

Heterocyclic sulfonamides

US8604025B2 · kind B2 · utility

3Cited by

3References

12Claims

0Family size

Assignee

CYTOKINETICS, INC. · US

Inventors

Bradley P. Morgan · Moraga, US
Fady Malik · Burlingame, US
Erica Anne Kraynack · South San Francisco, US
Alexander Ramon Muci · San Francisco, US
Xiangping Qian · Foster City, US
David J. Morgans, Jr. · Los Altos, US

Key dates

Filing date	Feb 5, 2013
Grant date	Dec 10, 2013
Priority date	—
Expiry date	Feb 5, 2033

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D403/12
WIPO fieldOrganic fine chemistry
WIPO sectorChemistry

Abstract

Certain substituted sulfonamide derivatives selectively modulate the cardiac sarcomere, for example by potentiating cardiac myosin, and are useful in the treatment of systolic heart failure including congestive heart failure.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.